Topic - Nancy Pekarek

Subscribe to this topic via RSS or ATOM
Related Stories
  • No Stories Found

More Stories →

  • "We look forward to the opportunity to present our data [today]. An expert forum is the place to discuss this complex science," Ms. Pekarek added.

    Panel to weigh Avandia's safety →

  • "Our view is that the sum of the data that we have available shows no increase in cardiovascular deaths and does not support a difference in heart-attack risk between Avandia and other common oral anti-diabetic medications," she said.

    Panel to weigh Avandia's safety →

Happening Now